Viroclinics-DDL rebrands to Cerba Research

Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study suggested. Among more than 200,000 individuals with

The crown jew­el from Bay­er’s 2020 buy­out of women’s health biotech KaNDy Ther­a­peu­tics has proven its worth in the clin­ic, meet­ing all pri­ma­ry and sec­ondary

Nearly half of all cardiology private practices were under private equity as of 2023, and there was a slight decrease in the proportion of groups